{"frequencyBands":{"HP:0040280":[100,100],"HP:0040281":[80,99],"HP:0040282":[30,79],"HP:0040283":[5,29],"HP:0040284":[1,4],"HP:0040285":[0,0]},"page":{"anchorSlug":"severe-combined-immunodeficiency-due-to-coro1a-deficiency","columns":[{"gene":"","key":"population-7cb7e860615f7da5fb32","label":"Immunodeficiency 8","mondoId":"MONDO:0014168","onsetQualifier":null,"originColumnKey":"MONDO:0014168/OMIM:615401","originalViews":[{"key":"MONDO:0014168/OMIM:615401","label":"Immunodeficiency 8","scopeLabel":"OMIM:615401","sourceScope":"Native source population. Existing approved source identity; no family evidence is inherited."}],"recordKeys":["2763f00a6868e6cff1b0770c109d9e160e47770bcf07bcba55e9030c800f3fa3","2d2efb73acb258d20da81dd3d8403ce1e550c1073a27b831eb291785de7fe977","411206baf44cacc4eb7934865a374a97f98cce6e46b9d8be9825dbcb3e59d626","6902a2231750816a0e3cae44742a39833a463ad62f2afdef049c153ccb43d969","6d1dc28a4e35219fedd6c8312e8677c5879dc6b6b2d5e2cf36cdcad391cb7eed","794cf686251b69cbcd95d33a4476f212b1c5e8c745b368b89e931ed2c25737b2","817988aab86982b829465536735053cf3c133323eb3d6657909c994de7af3b3b","c2c0d0d198d3c39b2f0fd3b7b9df38116ead61e512453bf168323afcd8df7fe2","d69bef48b8791e94b72147258961bc69f6840e2b9339cba321f1da80f2393e2d","dae6dfc6f8f544b79473d792f35d0d85da8b7fb809bd172459e60b19a5fd4779","fd2b17d132ccc21790df4b789bf1c963cd1223f37c72dcec0e8532a8c0af99ba","fe1e80d5d6ae89004486f40a5cd69dfeb80bb98090396f40c37b36dc8980c9d4"],"recordQualifiers":{},"scopeLabel":"OMIM:615401","sourceIds":["OMIM:615401"],"sourceScope":"Native source population. Existing approved source identity; no family evidence is inherited."}],"comparison":{"collapseColumnsLabel":"Show default populations","defaultColumnKeys":["population-7cb7e860615f7da5fb32"],"expandColumnsLabel":"Show all source populations","intro":"Features recorded for this MONDO node. Related-node evidence is available through separately scoped comparisons.","primaryFeatureIds":["HP:0007018","HP:0410295","HP:0410300","HP:0001888","HP:0002020","HP:0001263","HP:0002721"],"scopeNoteHtml":"<p>Each column retains its native condition identifier, assessed population and annotation references. Counts are not pooled.</p>"},"coverage":{"countRecords":11,"emptyColumnKeys":[],"hpoRelease":"2026-06-23","narrativeSourceChanges":[],"records":12,"sourceGroups":{"omim":1,"published":11}},"features":[{"hpoId":"HP:0007018","label":"Attention deficit hyperactivity disorder","primary":true},{"hpoId":"HP:0410295","label":"Complete or near-complete absence of specific antibody response to tetanus vaccine","primary":true},{"hpoId":"HP:0410300","label":"Complete or near-complete absence of specific antibody response to unconjugated pneumococcus polysaccharide","primary":true},{"hpoId":"HP:0001888","label":"Decreased total lymphocyte count","primary":true},{"hpoId":"HP:0002020","label":"Gastroesophageal reflux","primary":true},{"hpoId":"HP:0001263","label":"Global developmental delay","primary":true},{"hpoId":"HP:0002721","label":"Immunodeficiency","primary":true},{"hpoId":"HP:4000166","label":"Post-vaccination varicella zoster virus infection","primary":false},{"hpoId":"HP:0002783","label":"Recurrent lower respiratory tract infections","primary":false},{"hpoId":"HP:0009098","label":"Recurrent oral thrush","primary":false},{"hpoId":"HP:0000403","label":"Recurrent otitis media","primary":false},{"hpoId":"HP:0002788","label":"Recurrent upper respiratory tract infections","primary":false}],"ledeHtml":"A rare T-B+ severe combined immunodeficiency characterized by profoundly decreased levels of T-cells, normal B-cells, and low immunoglobulin levels. The thymus is present. Patients typically become symptomatic in infancy or early childhood with recurrent infections. Epstein-Barr virus (EBV)-associated B-cell lymphoproliferative syndrome/lymphoma and mucocutaneous-immunodeficiency syndrome have been reported in association. Some patients may show developmental delay, neurocognitive impairment, and behavioral dysfunction (in particular attention deficit-hyperactivity disorder).","mondoId":"MONDO:0014168","node":{"canonicalSlug":"severe-combined-immunodeficiency-due-to-coro1a-deficiency","comparisons":[{"documentSha256":"b7f8773690cb3a621e5f939c150c1154991ad121dd203469c08cdbf387e9821d","key":"legacy-severe-combined-immunodeficiency-due-to-coro1a-deficiency","kind":"legacy","label":"severe combined immunodeficiency due to CORO1A deficiency","memberIds":["MONDO:0014168"],"mondoId":"MONDO:0014168","url":"https://kcjyutqgtpgteszueluf.supabase.co/storage/v1/object/public/community-guides/learn-data/severe-combined-immunodeficiency-due-to-coro1a-deficiency.b7f8773690cb3a621e5f939c150c1154991ad121dd203469c08cdbf387e9821d.json"}],"contexts":[],"lifecycle":"active","narrative":{"causes":[],"contentForm":"summary","independentCorroborationEstablished":false,"matchMethod":"automatic-identity-and-attribution","name":"Severe combined immunodeficiency due to CORO1A deficiency","originalSourceId":"ORPHA:228003","paragraphs":["A rare T-B+ severe combined immunodeficiency characterized by profoundly decreased levels of T-cells, normal B-cells, and low immunoglobulin levels. The thymus is present. Patients typically become symptomatic in infancy or early childhood with recurrent infections. Epstein-Barr virus (EBV)-associated B-cell lymphoproliferative syndrome/lymphoma and mucocutaneous-immunodeficiency syndrome have been reported in association. Some patients may show developmental delay, neurocognitive impairment, and behavioral dysfunction (in particular attention deficit-hyperactivity disorder)."],"rawAttribution":"ORPHA:228003","reviewed":null,"scope":"exact","source":"GARD","sourceRelease":"2026-10-21T17:02:00Z","upstream":"ORPHA:228003","url":"https://rarediseases.info.nih.gov/diseases/17144"},"ownColumnKeys":["population-7cb7e860615f7da5fb32"],"publication":"published","relationships":[{"kind":"parent","label":"T-B+ severe combined immunodeficiency","mondoId":"MONDO:0044200","slug":"t-b-severe-combined-immunodeficiency-mondo-0044200"}],"schemaVersion":1,"searchIndex":"/node-search/manifest.json","sourceHolds":{},"summaryHolds":[],"translation":"pending"},"records":[{"frequencyKind":"count","key":"2763f00a6868e6cff1b0770c109d9e160e47770bcf07bcba55e9030c800f3fa3","raw":{"aspect":"P","body_system":"blood","disease_id":"OMIM:615401","disease_name":"Immunodeficiency 8","evidence":"PCS","frequency_raw":"1/1","hpo_id":"HP:0001888","is_excluded":false,"label":"Decreased total lymphocyte count","onset_id":null,"reference":"PMID:19097825","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"2d2efb73acb258d20da81dd3d8403ce1e550c1073a27b831eb291785de7fe977","raw":{"aspect":"P","body_system":"immune","disease_id":"OMIM:615401","disease_name":"Immunodeficiency 8","evidence":"PCS","frequency_raw":"1/1","hpo_id":"HP:0009098","is_excluded":false,"label":"Recurrent oral thrush","onset_id":null,"reference":"PMID:19097825","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"reported","key":"411206baf44cacc4eb7934865a374a97f98cce6e46b9d8be9825dbcb3e59d626","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"OMIM:615401","disease_name":"Immunodeficiency 8","evidence":"TAS","frequency_raw":null,"hpo_id":"HP:0001263","is_excluded":false,"label":"Global developmental delay","onset_id":null,"reference":"OMIM:615401","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"count","key":"6902a2231750816a0e3cae44742a39833a463ad62f2afdef049c153ccb43d969","raw":{"aspect":"P","body_system":"immune","disease_id":"OMIM:615401","disease_name":"Immunodeficiency 8","evidence":"PCS","frequency_raw":"1/1","hpo_id":"HP:0410300","is_excluded":false,"label":"Complete or near-complete absence of specific antibody response to unconjugated pneumococcus polysaccharide","onset_id":null,"reference":"PMID:19097825","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"6d1dc28a4e35219fedd6c8312e8677c5879dc6b6b2d5e2cf36cdcad391cb7eed","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"OMIM:615401","disease_name":"Immunodeficiency 8","evidence":"PCS","frequency_raw":"1/1","hpo_id":"HP:0007018","is_excluded":false,"label":"Attention deficit hyperactivity disorder","onset_id":null,"reference":"PMID:19097825","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"794cf686251b69cbcd95d33a4476f212b1c5e8c745b368b89e931ed2c25737b2","raw":{"aspect":"P","body_system":"immune","disease_id":"OMIM:615401","disease_name":"Immunodeficiency 8","evidence":"PCS","frequency_raw":"1/1","hpo_id":"HP:0000403","is_excluded":false,"label":"Recurrent otitis media","onset_id":null,"reference":"PMID:19097825","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"817988aab86982b829465536735053cf3c133323eb3d6657909c994de7af3b3b","raw":{"aspect":"P","body_system":"digestive","disease_id":"OMIM:615401","disease_name":"Immunodeficiency 8","evidence":"PCS","frequency_raw":"1/1","hpo_id":"HP:0002020","is_excluded":false,"label":"Gastroesophageal reflux","onset_id":null,"reference":"PMID:19097825","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"c2c0d0d198d3c39b2f0fd3b7b9df38116ead61e512453bf168323afcd8df7fe2","raw":{"aspect":"P","body_system":"immune","disease_id":"OMIM:615401","disease_name":"Immunodeficiency 8","evidence":"PCS","frequency_raw":"1/1","hpo_id":"HP:0410295","is_excluded":false,"label":"Complete or near-complete absence of specific antibody response to tetanus vaccine","onset_id":null,"reference":"PMID:19097825","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"d69bef48b8791e94b72147258961bc69f6840e2b9339cba321f1da80f2393e2d","raw":{"aspect":"P","body_system":"respiratory","disease_id":"OMIM:615401","disease_name":"Immunodeficiency 8","evidence":"PCS","frequency_raw":"1/1","hpo_id":"HP:0002788","is_excluded":false,"label":"Recurrent upper respiratory tract infections","onset_id":null,"reference":"PMID:19097825","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"dae6dfc6f8f544b79473d792f35d0d85da8b7fb809bd172459e60b19a5fd4779","raw":{"aspect":"P","body_system":"immune","disease_id":"OMIM:615401","disease_name":"Immunodeficiency 8","evidence":"PCS","frequency_raw":"1/1","hpo_id":"HP:0002721","is_excluded":false,"label":"Immunodeficiency","onset_id":null,"reference":"PMID:19097825","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"fd2b17d132ccc21790df4b789bf1c963cd1223f37c72dcec0e8532a8c0af99ba","raw":{"aspect":"P","body_system":"respiratory","disease_id":"OMIM:615401","disease_name":"Immunodeficiency 8","evidence":"PCS","frequency_raw":"1/1","hpo_id":"HP:0002783","is_excluded":false,"label":"Recurrent lower respiratory tract infections","onset_id":null,"reference":"PMID:19097825","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"fe1e80d5d6ae89004486f40a5cd69dfeb80bb98090396f40c37b36dc8980c9d4","raw":{"aspect":"P","body_system":"immune","disease_id":"OMIM:615401","disease_name":"Immunodeficiency 8","evidence":"PCS","frequency_raw":"1/1","hpo_id":"HP:4000166","is_excluded":false,"label":"Post-vaccination varicella zoster virus infection","onset_id":null,"reference":"PMID:19097825","source_release":"2026-06-23"},"sourceGroups":["published"]}],"referenceLabels":{},"references":{"causeHtml":"<p class=\"section-source\">Source: <a href=\"https://rarediseases.info.nih.gov/diseases/17144\" rel=\"noreferrer\">GARD</a></p><details class=\"deep-dive\"><summary>Narrative source and scope</summary><dl><dt>Content</dt><dd>summary</dd><dt>Scope</dt><dd>exact</dd><dt>Match method</dt><dd>automatic-identity-and-attribution</dd><dt>Upstream attribution</dt><dd>ORPHA:228003</dd></dl></details>","identityNote":"MONDO identifies this node. Native source populations, annotation references and qualified comparison views retain their original scopes.","importantHtml":""},"sections":[{"bodyHtml":"<p>A rare T-B+ severe combined immunodeficiency characterized by profoundly decreased levels of T-cells, normal B-cells, and low immunoglobulin levels. The thymus is present. Patients typically become symptomatic in infancy or early childhood with recurrent infections. Epstein-Barr virus (EBV)-associated B-cell lymphoproliferative syndrome/lymphoma and mucocutaneous-immunodeficiency syndrome have been reported in association. Some patients may show developmental delay, neurocognitive impairment, and behavioral dysfunction (in particular attention deficit-hyperactivity disorder).</p><p class=\"section-source\">Source: <a href=\"https://rarediseases.info.nih.gov/diseases/17144\" rel=\"noreferrer\">GARD</a></p>","key":"overview","title":"Overview"}],"sharedSources":[],"slug":"severe-combined-immunodeficiency-due-to-coro1a-deficiency","sourceDocuments":[{"name":"GARD: Severe combined immunodeficiency due to CORO1A deficiency","reviewed":null,"source_release":"2026-10-21T17:02:00Z","url":"https://rarediseases.info.nih.gov/diseases/17144"}],"sourceNote":"","synonyms":["coronin-1A deficiency","IMD8","immunodeficiency 8","immunodeficiency type 8","SCID due to CORO1A deficiency","SCID due to coronin-1A deficiency","severe combined immunodeficiency due to CORO1A deficiency","severe combined immunodeficiency due to coronin-1A deficiency"],"takeawayHtml":"","title":"severe combined immunodeficiency due to CORO1A deficiency"},"schemaVersion":1}
